Oncologix Continues Expansion; Signs Letter of Intent With Private Pay Healthcare Service Provider
10 Ottobre 2013 - 2:50PM
Marketwired
Oncologix Continues Expansion; Signs Letter of Intent With Private
Pay Healthcare Service Provider
ALEXANDRIA, LA--(Marketwired - Oct 10, 2013) - Oncologix Tech
Inc. (OTCQB: OCLG), announced today that it has signed a Letter of
Intent to acquire a Private Pay healthcare service provider.
Wayne Erwin, CEO of OCLG, stated, "We have signed a letter of
intent with a provider of private pay services to the elderly and
to Veterans Administration clients. We expect to announce the
details of this transaction within the next 45 days. The
Letter of Intent continues our Company strategic mission."
With the recent acquisition of Angels of Mercy, Inc, a leading
Personal Care Attendant service provider now complete, we will
merge these operations into Angels. The combined synergies
will allow Angels of Mercy to become the leading PCA healthcare
service provider in the State of Louisiana with over 248 employees
and $3.8 million in annual revenues, thereby continuing with the
Company's core mission. OCLG is determined to position the Company
for long-term growth and profitability built on the strength of its
existing operations and new health care service acquisitions.
Oncologix operates medical device and healthcare services
companies. For its clients, Oncologix provides FDA approved medical
devices and State licensed healthcare services. For its
shareholders, Oncologix operates profitable operations that build,
maintain and nourish shareholder value. The Company's corporate
mission is to be the best small cap medical device and healthcare
services company in North America.
This press release may contain forward-looking statements, made
in reliance upon Section 21D of the Exchange Act of 1934, which
involve known and unknown risks, uncertainties or other factors
that could cause actual results to differ materially from the
results, performance, or expectations implied by these
forward-looking statements. The Company's expectations, among other
things, are dependent upon economic conditions, continued demand
for its products, the availability of raw materials, retention of
its key management and operating personnel, its ability to operate
its subsidiary companies effectively, need for and availability of
more capital as well as other uncontrollable or unknown factors
which are more fully disclosed in the Company's filings with the
Securities and Exchange Commission.
CONTACT
INFORMATION Wayne Erwin CEO Email Contact (318)769-1958
INVESTOR RELATIONS Jack Eversull President The Eversull Group, Inc.
972-571-1624 214-469-2361 fax Email Contact Green Arrow Consultants
(760) 565-7503
Grafico Azioni Oncologix Tech (CE) (USOTC:OCLG)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Oncologix Tech (CE) (USOTC:OCLG)
Storico
Da Gen 2024 a Gen 2025
